These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 30005555

  • 21. Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.
    Vrtovec B, Poglajen G, Lezaic L, Sever M, Socan A, Domanovic D, Cernelc P, Torre-Amione G, Haddad F, Wu JC.
    Circulation; 2013 Sep 10; 128(11 Suppl 1):S42-9. PubMed ID: 24030420
    [Abstract] [Full Text] [Related]

  • 22. Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial.
    Suncion VY, Ghersin E, Fishman JE, Zambrano JP, Karantalis V, Mandel N, Nelson KH, Gerstenblith G, DiFede Velazquez DL, Breton E, Sitammagari K, Schulman IH, Taldone SN, Williams AR, Sanina C, Johnston PV, Brinker J, Altman P, Mushtaq M, Trachtenberg B, Mendizabal AM, Tracy M, Da Silva J, McNiece IK, Lardo AC, George RT, Hare JM, Heldman AW.
    Circ Res; 2014 Apr 11; 114(8):1292-301. PubMed ID: 24449819
    [Abstract] [Full Text] [Related]

  • 23. Predictive values of left ventricular mechanical dyssynchrony for CRT response in heart failure patients with different pathophysiology.
    He Z, Li D, Cui C, Qin HY, Zhao Z, Hou X, Zou J, Chen ML, Wang C, Zhou W.
    J Nucl Cardiol; 2022 Oct 11; 29(5):2637-2648. PubMed ID: 34535872
    [Abstract] [Full Text] [Related]

  • 24. Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials.
    Ramireddy A, Brodt CR, Mendizabal AM, DiFede DL, Healy C, Goyal V, Alansari Y, Coffey JO, Viles-Gonzalez JF, Heldman AW, Goldberger JJ, Myerburg RJ, Hare JM, Mitrani RD.
    Stem Cells Transl Med; 2017 May 11; 6(5):1366-1372. PubMed ID: 28252842
    [Abstract] [Full Text] [Related]

  • 25. Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.
    Luger D, Lipinski MJ, Westman PC, Glover DK, Dimastromatteo J, Frias JC, Albelda MT, Sikora S, Kharazi A, Vertelov G, Waksman R, Epstein SE.
    Circ Res; 2017 May 12; 120(10):1598-1613. PubMed ID: 28232595
    [Abstract] [Full Text] [Related]

  • 26. Impact of repeated intravenous bone marrow mesenchymal stem cells infusion on myocardial collagen network remodeling in a rat model of doxorubicin-induced dilated cardiomyopathy.
    Yu Q, Li Q, Na R, Li X, Liu B, Meng L, Liutong H, Fang W, Zhu N, Zheng X.
    Mol Cell Biochem; 2014 Feb 12; 387(1-2):279-85. PubMed ID: 24257807
    [Abstract] [Full Text] [Related]

  • 27. The ixCELL-DCM Trial: Rationale and Design.
    Henry TD, Schaer GL, DeMaria A, Recker D, Remmers AE, Goodrich J, Patel AN.
    Cell Transplant; 2016 Feb 12; 25(9):1689-1699. PubMed ID: 27009022
    [Abstract] [Full Text] [Related]

  • 28. A Randomized Comparative Study on the Efficacy of Intracoronary Infusion of Autologous Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells in Patients With Dilated Cardiomyopathy.
    Xiao W, Guo S, Gao C, Dai G, Gao Y, Li M, Wang X, Hu D.
    Int Heart J; 2017 Apr 06; 58(2):238-244. PubMed ID: 28190794
    [Abstract] [Full Text] [Related]

  • 29. The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy-a meta analysis.
    Nso N, Bookani KR, Enoru ST, Radparvar F, Gordon R.
    Heart Fail Rev; 2022 May 06; 27(3):811-820. PubMed ID: 33587248
    [Abstract] [Full Text] [Related]

  • 30. Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study).
    Martino H, Brofman P, Greco O, Bueno R, Bodanese L, Clausell N, Maldonado JA, Mill J, Braile D, Moraes J, Silva S, Bozza A, Santos B, Campos de Carvalho A, Dilated Cardiomyopathy Arm of the MiHeart Study Investigators.
    Eur Heart J; 2015 Nov 07; 36(42):2898-904. PubMed ID: 26392433
    [Abstract] [Full Text] [Related]

  • 31. A pilot trial to assess potential effects of selective intracoronary bone marrow-derived progenitor cell infusion in patients with nonischemic dilated cardiomyopathy: final 1-year results of the transplantation of progenitor cells and functional regeneration enhancement pilot trial in patients with nonischemic dilated cardiomyopathy.
    Fischer-Rasokat U, Assmus B, Seeger FH, Honold J, Leistner D, Fichtlscherer S, Schächinger V, Tonn T, Martin H, Dimmeler S, Zeiher AM.
    Circ Heart Fail; 2009 Sep 07; 2(5):417-23. PubMed ID: 19808371
    [Abstract] [Full Text] [Related]

  • 32. Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy.
    Miyagawa S, Domae K, Yoshikawa Y, Fukushima S, Nakamura T, Saito A, Sakata Y, Hamada S, Toda K, Pak K, Takeuchi M, Sawa Y.
    J Am Heart Assoc; 2017 Apr 05; 6(4):. PubMed ID: 28381469
    [Abstract] [Full Text] [Related]

  • 33. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure.
    Kissel CK, Lehmann R, Assmus B, Aicher A, Honold J, Fischer-Rasokat U, Heeschen C, Spyridopoulos I, Dimmeler S, Zeiher AM.
    J Am Coll Cardiol; 2007 Jun 19; 49(24):2341-9. PubMed ID: 17572250
    [Abstract] [Full Text] [Related]

  • 34. Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
    Bobbo M, Pinamonti B, Merlo M, Stolfo D, Iorio A, Ramani F, Barbati G, Carriere C, Massa L, Poli S, Scapol S, Gigli M, Di Lenarda A, Sinagra G.
    Am J Cardiol; 2017 Feb 01; 119(3):483-489. PubMed ID: 27988039
    [Abstract] [Full Text] [Related]

  • 35. REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy.
    Garcia-Pavia P, Palomares JFR, Sinagra G, Barriales-Villa R, Lakdawala NK, Gottlieb RL, Goldberg RI, Elliott P, Lee P, Li H, Angeli FS, Judge DP, MacRae CA, REALM-DCM Investigators.
    Circ Heart Fail; 2024 Jul 01; 17(7):e011548. PubMed ID: 38979608
    [Abstract] [Full Text] [Related]

  • 36. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling.
    Williams AR, Trachtenberg B, Velazquez DL, McNiece I, Altman P, Rouy D, Mendizabal AM, Pattany PM, Lopera GA, Fishman J, Zambrano JP, Heldman AW, Hare JM.
    Circ Res; 2011 Apr 01; 108(7):792-6. PubMed ID: 21415390
    [Abstract] [Full Text] [Related]

  • 37. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J, Verdugo FJ, González PL, Larrea RE, Abarzua E, Goset C, Rojo P, Palma I, Lamich R, Pedreros PA, Valdivia G, Lopez VM, Nazzal C, Alcayaga-Miranda F, Cuenca J, Brobeck MJ, Patel AN, Figueroa FE, Khoury M.
    Circ Res; 2017 Oct 27; 121(10):1192-1204. PubMed ID: 28974553
    [Abstract] [Full Text] [Related]

  • 38. Effects of Repetitive Transendocardial CD34+ Cell Transplantation in Patients With Nonischemic Dilated Cardiomyopathy.
    Vrtovec B, Poglajen G, Sever M, Zemljic G, Frljak S, Cerar A, Cukjati M, Jaklic M, Cernelc P, Haddad F, Wu JC.
    Circ Res; 2018 Jul 20; 123(3):389-396. PubMed ID: 29880546
    [Abstract] [Full Text] [Related]

  • 39. Stem cell therapy for dilated cardiomyopathy.
    Diaz-Navarro R, Urrútia G, Cleland JG, Poloni D, Villagran F, Acosta-Dighero R, Bangdiwala SI, Rada G, Madrid E.
    Cochrane Database Syst Rev; 2021 Jul 21; 7(7):CD013433. PubMed ID: 34286511
    [Abstract] [Full Text] [Related]

  • 40. Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial.
    Butler J, Epstein SE, Greene SJ, Quyyumi AA, Sikora S, Kim RJ, Anderson AS, Wilcox JE, Tankovich NI, Lipinski MJ, Ko YA, Margulies KB, Cole RT, Skopicki HA, Gheorghiade M.
    Circ Res; 2017 Jan 20; 120(2):332-340. PubMed ID: 27856497
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.